13F Holdings
中文EN

XRAY DENTSPLY SIRONA Inc.

Dental Equipment & Supplies · Nasdaq · SEC CIK 818479 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-1.4%
TTM net income YoY86.3%
TTM EPS YoY86.1%
Revenue 3-yr CAGR-3.2%
Net income 3-yr CAGR—

Margins

Gross margin50.5%
Operating margin-1.5%
Net margin-3.4%
FCF margin2.9%
EBITDA margin7.9%

Returns

ROE-8.5%
ROA-2.2%
ROIC (approx.)-1.3%
Asset turnover0.66x

Leverage & solvency

Liabilities / assets73.9%
Debt / equity1.62x
Current ratio1.63x
Interest coverage-0.59x

Cash quality & payout

Operating cash flow / net income-2.25x
Accruals ratio-7.2%
Payout ratio—
Capex / revenue4.7%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$3.68B$3.79B$3.96B$3.92B$4.23B
Cost of revenue$1.84B$1.83B$1.88B$1.79B$1.88B
Gross profit$1.84B$1.96B$2.09B$2.13B$2.35B
R&D expense$150.00M$165.00M$184.00M$174.00M$171.00M
SG&A expense$1.44B$1.60B$1.61B$1.59B$1.55B
Operating income-$422.00M-$879.00M-$85.00M-$937.00M$608.00M
Interest expense$88.00M$69.00M$81.00M$65.00M$61.00M
Pretax income-$486.00M-$936.00M-$175.00M-$1.05B$545.00M
Income tax$112.00M-$26.00M-$43.00M-$105.00M$134.00M
Net income-$598.00M-$910.00M-$132.00M-$950.00M$411.00M
EBITDA-$70.00M-$530.00M$258.00M-$609.00M$955.00M
EPS (basic)-3.00-4.48-0.62-4.411.88
EPS (diluted)-3.00-4.48-0.62-4.411.87
Dividends declared per share0.640.640.560.500.43
Weighted avg. shares (diluted)199.40M203.20M212.00M215.50M220.20M
Balance sheet
Cash & equivalents$326.00M$272.00M$334.00M$365.00M$339.00M
Inventory$642.00M$564.00M$624.00M$627.00M$515.00M
Current assets$2.02B$1.75B$1.97B$1.89B$1.85B
PP&E, net$861.00M$766.00M$800.00M$761.00M$773.00M
Goodwill$1.15B$1.60B$2.44B$2.69B$3.98B
Intangibles$974.00M$1.21B$1.71B$1.90B$2.32B
Total assets$5.43B$5.75B$7.37B$7.64B$9.24B
Current liabilities$1.34B$1.59B$1.43B$1.17B$1.26B
Short-term debt$313.00M$549.00M$322.00M$118.00M$182.00M
Long-term debt$2.02B$1.59B$1.80B$1.83B$1.91B
Total debt$2.33B$2.13B$2.12B$1.94B$2.10B
Total liabilities$4.09B$3.81B$4.08B$3.83B$4.24B
Shareholders' equity$1.34B$1.94B$3.29B$3.81B$5.00B
Net debt$2.00B$1.86B$1.78B$1.58B$1.76B
Shares outstanding199.60M198.80M207.20M215.20M217.40M
Cash flow statement
Operating cash flow$235.00M$461.00M$377.00M$517.00M$657.00M
Capital expenditure$131.00M$180.00M$149.00M$149.00M$142.00M
Free cash flow$104.00M$281.00M$228.00M$368.00M$515.00M
Investing cash flow-$132.00M-$197.00M-$89.00M-$138.00M-$358.00M
Financing cash flow-$80.00M-$302.00M-$307.00M-$329.00M-$379.00M
Depreciation & amortization$352.00M$349.00M$343.00M$328.00M$347.00M
Stock-based compensation$33.00M$39.00M$46.00M$59.00M$48.00M
Dividends paid$128.00M$126.00M$116.00M$104.00M$92.00M
Share buybacks$0$250.00M$300.00M$150.00M$200.00M

Free plan shows the latest 5 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.